PharmacoEconomics, 1170-7690

Journal

Publications

  1. 2019
  2. E-pub ahead of print

    Cost-utility analyses of interventions for informal carers: a systematic and critical review

    Hareth Al-Janabi, 19 Dec 2019, (E-pub ahead of print) In: PharmacoEconomics. 16 p.

    Research output: Contribution to journalReview articlepeer-review

  3. E-pub ahead of print
  4. Published
  5. 2018
  6. Published
  7. Published
  8. Published
  9. 2017
  10. Published
  11. Published

    How qualitative methods can be used to inform model development

    Sue Jowett, Pelham Barton, Jun 2017, In: PharmacoEconomics. 35, 6, p. 607-612

    Research output: Contribution to journalArticlepeer-review

  12. 2016
  13. Published
  14. E-pub ahead of print

    Economic evaluation of childhood obesity interventions: reflections and suggestions

    Emma Frew, 11 Mar 2016, (E-pub ahead of print) In: PharmacoEconomics. 34, 8, p. 733-740

    Research output: Contribution to journalArticlepeer-review

  15. 2015
  16. Published

    Evaluating the Generalisability of Trial Results: Introducing a Centre- and Trial-Level Generalisability Index

    Tracy Roberts, Karla Hemming & Melanie Calvert, Nov 2015, In: PharmacoEconomics. 33, 11, p. 1195-1214 20 p.

    Research output: Contribution to journalArticlepeer-review

  17. Published

    Exploring the use of cost-benefit analysis to compare pharmaceutical treatments for menorrhagia

    Sabina Sanghera, Emma Frew, Janesh Gupta & Tracy Roberts, Sep 2015, In: PharmacoEconomics. 33, 9, p. 957-965 9 p.

    Research output: Contribution to journalArticlepeer-review

  18. Published

    Adapting the CHEERS statement for Reporting Cost Benefit Analysis

    Sabina Sanghera, Emma Frew & Tracy Roberts, May 2015, In: PharmacoEconomics. 33, 5

    Research output: Contribution to journalLetterpeer-review

  19. 2011
  20. Published

    QALYs and Carers

    Hareth Al-Janabi & Jo Coast, 11 Oct 2011, In: PharmacoEconomics. 29, 12, p. 1015-1023 9 p.

    Research output: Contribution to journalArticlepeer-review

  21. Published
  22. 2010
  23. Published
  24. Published
  25. 2009
  26. Published

    New anticoagulants for the prevention of deep venous thrombosis: time to consider cost effectiveness?

    Gregory Lip, 1 Jan 2009, In: PharmacoEconomics. 27, 10, p. 793-5 3 p.

    Research output: Contribution to journalArticle

  27. Published

    The applicability and generalizability of findings from clinical trials for health-policy decisions.

    Nick Freemantle, 1 Jan 2009, In: PharmacoEconomics. 27, 1, p. 5-10 6 p.

    Research output: Contribution to journalArticle

  28. 2008
  29. Published
  30. 2007
  31. Published

    Is medication review by pharmacists of any use?

    Nick Freemantle, Feb 2007, In: PharmacoEconomics. 25, 2, p. 91-92 2 p.

    Research output: Contribution to journalEditorial

  32. 2006
  33. Published

    How much is the cost of blindness? Caveat Emptor

    Catherine Meads & Christopher Hyde, 1 Jan 2006, In: PharmacoEconomics. 24, 2, p. 207-209 3 p.

    Research output: Contribution to journalArticle

  34. Published

    NICE says no to inhaled insulin: What lessons should we learn?

    Nick Freemantle, 1 Jan 2006, In: PharmacoEconomics. 24, 7, p. 627-629 3 p.

    Research output: Contribution to journalEditorial

  35. 2005
  36. Published

    Real world trials to answer real world questions

    Nick Freemantle, Richard Hobbs, 1 Jan 2005, In: PharmacoEconomics. 23, p. 747-754 8 p.

    Research output: Contribution to journalArticle

  37. 2004
  38. Published

    Cost Effective Strategies in the Prevention of Diabetic Nephropathy

    Jonathan Rippin, Tony Barnett & Stephen Bain, 1 Jan 2004, In: PharmacoEconomics. 22, p. 9-28 20 p.

    Research output: Contribution to journalArticle

  39. 2003
  40. Published

    A role of two-stage pharmacoeconomic appraisal?

    Nick Freemantle, 1 Jan 2003, In: PharmacoEconomics. 21, p. 761-767 7 p.

    Research output: Contribution to journalArticle

  41. 2002
  42. Published

    A fair innings for NICE?

    Nick Freemantle & Joanne Eastaugh, 1 Jan 2002, In: PharmacoEconomics. 20, 6, p. 389-391 3 p.

    Research output: Contribution to journalArticle

  43. Published

    Developing revised NICE Appraisal Technical Guidance to Manufacturers and Sponsors: opportunity or threat?

    Rodney Taylor, 1 Jan 2002, In: PharmacoEconomics. 20, 15, p. 1031-1038 8 p.

    Research output: Contribution to journalArticle

  44. 2001
  45. Published

    Using health outcomes data to inform decision-making - Government Agency Perspective

    Rodney Taylor, 1 Jan 2001, In: PharmacoEconomics. 19, p. 33-38 6 p.

    Research output: Contribution to journalArticle